Geeneerikoiden

Geeneerikoiden, also known as generic drugs, are pharmaceutical products that are chemically identical to their brand-name counterparts. They are produced by generic drug manufacturers and are typically less expensive than brand-name drugs. The process of creating a generic drug involves reverse engineering the active ingredient of the original drug, ensuring that it has the same molecular structure, dosage form, strength, route of administration, quality, performance characteristics, and intended use.

Generic drugs are subject to rigorous testing and approval processes to ensure their safety, efficacy, and quality. They must meet the same standards as brand-name drugs and are regulated by various authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Generic drugs are widely used in healthcare systems around the world due to their affordability and accessibility.

The development of generic drugs is an essential part of the pharmaceutical industry, as it helps to increase competition, drive down prices, and make medications more accessible to patients. Generic drugs play a crucial role in healthcare, particularly in low- and middle-income countries, where they can significantly reduce the cost of treatment and improve patient outcomes.